Institutional Ownership
Inovio Pharmaceuticals Inc
CUSIP 45773H409COM SHSINOQ1 2026
13D / 13G Filings
19
Schedule 13D/13G on record
Beneficial Filers
9
Distinct reporting persons
Largest Stake
14.8%
Max % of class reported
Institutional Holders
97
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
19 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Alyeska Investment Group, L.P. | 13G/A | 6.0% | 4.00M | SEC |
| 2 | Jan 30, 2026 | The Vanguard Group | 13G/A | 5.0% | 3.32M | SEC |
| 3 | Dec 8, 2025 | Janus Henderson Group PLC | 13G/A | 10.0% | 6.67M | SEC |
| 4 | Dec 5, 2025 | Fmr LLC | 13G | 14.8% | 9.85M | SEC |
| 5 | Nov 14, 2025 | Janus Henderson Group PLC | 13G | 6.2% | 3.27M | SEC |
| 6 | Nov 14, 2025 | Alyeska Investment Group, L.P. | 13G | 7.5% | 4.00M | SEC |
| 7 | Nov 14, 2025 | Deep Track Capital, LP | 13G/A | 2.4% | 1.31M | SEC |
| 8 | Nov 13, 2025 | Adage Capital Management, L.P. | 13G | 10.0% | 5.52M | SEC |
| 9 | Jul 17, 2025 | Blackrock, Inc. | 13G/A | 1.5% | 537.6K | SEC |
| 10 | May 14, 2025 | Stonepine Capital Management, LLC | 13G/A | 3.8% | — | SEC |
9 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Inovio Pharmaceuticals Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Fmr LLC | 9.34M | $16.25M |
| 2 | Janus Henderson Group PLC | 3.31M | $5.77M |
| 3 | Boxer Capital Management, LLC | 2.37M | $4.12M |
| 4 | D. E. Shaw & Co., Inc. | 2.21M | $3.85M |
| 5 | Adar1 Capital Management, LLC | 1.47M | $2.56M |
| 6 | Millennium Management LLC | 1.41M | $2.45M |
| 7 | Eversept Partners, LP | 1.04M | $1.80M |
| 8 | Adage Capital Partners Gp, L.L.C. | 805.0K | $1.40M |
| 9 | Geode Capital Management, LLC | 801.5K | $1.40M |
| 10 | Blackrock, Inc. | 662.2K | $1.15M |